- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 215/227 - Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
Patent holdings for IPC class C07D 215/227
Total number of patents in this class: 365
10-year publication summary
|
28
|
54
|
31
|
40
|
23
|
30
|
23
|
18
|
17
|
7
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3839 |
24 |
| Alkermes Pharma Ireland Limited | 307 |
17 |
| Gilead Sciences, Inc. | 1879 |
12 |
| Corteva Agriscience LLC | 2494 |
8 |
| Syngenta Participations AG | 4970 |
7 |
| Amgen Inc. | 3779 |
6 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
6 |
| Abbvie Inc. | 1808 |
6 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 211 |
6 |
| The Regents of the University of California | 18943 |
5 |
| Syngenta Limited | 509 |
5 |
| Bayer Pharma AG | 1096 |
5 |
| Biogen MA Inc. | 926 |
5 |
| General Mills, Inc. | 990 |
5 |
| Otsuka Pharmaceutical Co., Ltd. | 1426 |
5 |
| Boehringer Ingelheim International GmbH | 4629 |
4 |
| AbbVie Deutschland GmbH & Co. KG | 268 |
4 |
| Vertex Pharmaceuticals Incorporated | 1581 |
4 |
| Crystal Pharma, S.A.U. | 51 |
4 |
| Forma Therapeutics, Inc. | 164 |
4 |
| Other owners | 223 |